Informations générales (source: ClinicalTrials.gov)
REAL WORLD DATA IN LYMPHOMA AND SURVIVAL IN ADULTS (REALYSA)
Observational [Patient Registry]
Hospices Civils de Lyon (Voir sur ClinicalTrials)
novembre 2018
novembre 2027
29 juin 2024
REALYSA cohort is a population-based epidemiological platform in real-life for lymphomas
designed to enrich prognostic data, by integrating together epidemiological, clinical and
biological data.
REALYSA is a platform perfectly set up to
- Study prognostic factors using integrated epidemiological and biological data
(genetics), to better characterize the determinants of refractoriness and relapse in
patients with lymphoma, to follow the growing number of survivors and describe
median to long-term sequela, second cancer, quality of life (QoL)...
- Document treatment effectiveness in real life and observance
- Address socio-economical questions
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 04/12/2024 12:44:19 | Contacter | |||
| CLCC RENE HUGUENIN INSTITUT CURIE | 04/12/2024 12:44:05 | Contacter | |||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Henri Mondor-Albert Chenevier | Corinne HAIOUN, PhD | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier Lyon Sud - Pierre-Bénite - France | Hervé Ghesquières, MD | Contact (sur clinicalTrials) | |||
| CHD Vendée - La Roche-sur-Yon - France | Nadine MORINEAU, MD | Contact (sur clinicalTrials) | |||
| CHU Francois MITTERRAND - Dijon - France | René-Olivier CASASNOVAS, MD | Contact (sur clinicalTrials) | |||
| CHU Haut-Lévêque - Pessac - France | Kamal-Krimo BOUABDALLAH, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier de Niort - 79021 - Niort - France | Gaëlle Olivier, MD | Contact (sur clinicalTrials) | |||
| Centre hospitalier Libourne - 33500 - Libourne - France | Gaelle LABOURE, MD | Contact (sur clinicalTrials) | |||
| Centre Hospitalier Pierre Oudot - 38302 - Bourgoin-Jallieu - France | Florence LACHENAL, MD | Contact (sur clinicalTrials) | |||
| Clinique Victor Hugo - 72000 - Le Mans - France | Katell LE DÛ, MD | Contact (sur clinicalTrials) | |||
| Département d'Hématologie Clinique et Thérapie Cellulaire, Institut de Cancérologie Lucien Neuwirth - 42270 - Saint-Priest-en-Jarez - France | Ludovic FOUILLET, MD | Contact (sur clinicalTrials) | |||
| Département d'Hématologie Clinique, Hôpital Saint-Eloi, - 34295 - Montpellier - France | Guillaume CARTRON, PhD | Contact (sur clinicalTrials) | |||
| Département d'Hématologie et Oncologie, Centre Léon Bérard - 69008 - Lyon - France | Laure LEBRAS, MD | Contact (sur clinicalTrials) | |||
| Hématologie Clinique, CH DE BRETAGNE ATLANTIQUE - 56017 - Vannes - France | Antoine BONNET, MD | Contact (sur clinicalTrials) | |||
| Hématologie Clinique, CHU PONTCHAILLOU - 35033 - Rennes - France | Thierry LAMY DE LA CHAPELLE, PhD | Contact (sur clinicalTrials) | |||
| Hôpitaux Universitaires de Strasbourg - Strasbourg - France | Luc-Matthieu FORNECKER, MD | Contact (sur clinicalTrials) | |||
| Institut Universitaire du Cancer - Toulouse - France | Loïc YSEBAERT, MD | Contact (sur clinicalTrials) | |||
| METROPOLE SAVOIE - SITE CHAMBERY, place Lucien Biset, - 73000 - Chambéry - France | Gian Matteo PICA, MD | Contact (sur clinicalTrials) | |||
| Service des maladies du sang, Hôpital Claude Huriez, CHRU de Lille - 59037 - Lille - France | Franck MORSCHHAUSER, MD | Contact (sur clinicalTrials) | |||
| Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Estaing, CHU de Clermont-Ferrand - 63000 - Clermont-Ferrand - France | Romain GUIEZE, PhD | Contact (sur clinicalTrials) | |||
| Service d'Hématologie clinique, Centre Hospitalier Universitaire de Nantes - 44093 - Nantes - France | Thomas GASTINNE, PhD | Contact (sur clinicalTrials) | |||
| Service d'Hématologie Clinique, Centre Hospitalier Universitaire Michallon - 38700 - La Tronche - France | Rémy GRESSIN, MD | Contact (sur clinicalTrials) | |||
| Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire de Poitiers - 86021 - Poitiers - France | Stéphanie GUIDEZ, MD | Contact (sur clinicalTrials) | |||
| Service d'Hématologie, CHU Jean Minjoz - 25030 - Besançon - France | Adrien CHAUCHET, MD | Contact (sur clinicalTrials) | |||
| Service d'Hématologie, Institut d'Hématologie de Basse Normandie - 14000 - Caen - France | Gandhi DAMAJ, PhD | Contact (sur clinicalTrials) | |||
| Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine - 33300 - Bordeaux - France | Olivier FITOUSSI, MD | Contact (sur clinicalTrials) | |||
| Service Hématologie Clinique et Thérapie Cellulaire, CHU DE LIMOGES - HOPITAL DUPUYTREN, - 87042 - Limoges - France | Julie ABRAHAM, MD | Contact (sur clinicalTrials) | |||
| Service Hématologie, Centre Hospitalier de Dunkerque - 59140 - Dunkerque - France | Christophe FRUCHART, MD | Contact (sur clinicalTrials) | |||
| Service Hématologie, Centre Hospitalier de Roubaix - Hôpital Victor Provo - 59056 - Roubaix - France | Laurence DETOURMIGNIES, MD | Contact (sur clinicalTrials) | |||
| Service Hématologie, CH YVES LE FOLL - 22027 - Saint-Brieuc - France | Vincent LAUNAY, MD | Contact (sur clinicalTrials) | |||
| Service Hématologie, GH REGION MULHOUSE ET SUD ALSACE - HOPITAL EMILE MULLER, - 68070 - Mulhouse - France | Bernard DRENOU, MD | Contact (sur clinicalTrials) | |||
| Service Hématologie, Hôpital St Louis - 75475 - Paris - France | Catherine THIEBLEMONT, PhD | Contact (sur clinicalTrials) | |||
| Service Hématologie, UNIVERSITE DE ROUEN, CENTRE HENRI BECQUEREL - 76038 - Rouen - France | Fabrice JARDIN, PhD | Contact (sur clinicalTrials) | |||
| Service Oncologie médicale, Groupe Hospitalier Mutualiste de Grenoble, Institut Daniel Hollard, - 38028 - Grenoble - France | Cécile LEYRONNAS, MD | Contact (sur clinicalTrials) | |||
| Service Oncologie médicale, HOPITAL SAINT VINCENT-DE-PAUL - 59020 - Lille - France | Sandy AMORIM, MD | Contact (sur clinicalTrials) | |||
| Unité d'Hématologie Clinique, CH D'ARRAS - 62022 - Arras - France | Pauline LIONNE-HUYGHE, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Signature of the consent form for participation in the REALYSA cohort
- Aged over 18 at the time of inclusion
- Diagnosed with lymphoma in the last 6 months (180 days)
- Lymphoma subtype belonging to at least one of the 7 histological subtypes: diffuse
large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone
lymphoma, T-cell lymphoma, Hodgkin's lymphoma, Burkitt lymphoma
- Signature of the consent form for participation in the REALYSA cohort
- Aged over 18 at the time of inclusion
- Diagnosed with lymphoma in the last 6 months (180 days)
- Lymphoma subtype belonging to at least one of the 7 histological subtypes: diffuse
large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone
lymphoma, T-cell lymphoma, Hodgkin's lymphoma, Burkitt lymphoma
- Anti-lymphoma treatment already received (except pre-phase: typically
corticosteroids, vincristine, cyclophosphamide, etoposide, alone or in combination)
- Documented HIV infection
- Any other lymphoma subtype not included in the list in Appendix 1. Of note, are
excluded:
- Chronic lymphocytic leukemia/small lymphocytic lymphoma
- Hairy cell leukemia and variant
- Lymphoplasmacytic lymphoma
- Waldenström macroglobulinemia
- Primary DLBCL of the central nervous system (CNS)
- T-cell large granular lymphocytic leukemia
- Chronic lymphoproliferative disorder of NK cells
- Mycosis fungoides
- Sézary syndrome
- Primary cutaneous T cell lymphomas (mainly diagnosed and treated by
dermatologists)
- Post-transplant lymphoproliferative disorders (PTLD)